P. T. F. McLoughlin et al. / Tetrahedron 60 (2004) 8065–8071
8069
procedure26 in 62% yield from the reaction of cyanogen
bromide with N-methylimidazole.
1 h via a syringe pump to 5-bromo-1,2-dimethyimidazole 1
(1.09 g, 6 mmol) and AIBN (0.98 g, 6 mmol) in pyridine
(90 ml). The reaction was refluxed for a further 1 h, cooled
and evaporated to dryness. The work-up and purification
procedure used for the benzene reaction was repeated. The
first product eluted by column chromatography was 8
(0.47 g, 45%) as a yellow oil. (Found MC, 173.0954,
C10H11N3 requires MC 173.0953), nmax/cmK1 1658, 1589,
1562, 1501, 1437, 1401; dH 2.39 (s, 3H, Im-2-Me), 3.85 (s,
3H, N–Me), 7.08 (m, 1H, py-H-5), 7.24 (s, 1H, Im-4-H),
7.46 (d, JZ7.8 Hz, 1H, py-3-H), 7.62 (m, 1H, py-H-4), 8.53
(d, JZ2.4 Hz, 1H, py-6-H); dC 13.5 (Me), 32.4 (N–Me),
121.0 (py-CH), 121.5 (py-CH), 128.3 (Im-4-CH), 132.0 (C),
136.4 (CH), 147.5 (C), 148.7 (py-6-CH), 150.6 (C); m/z 173
(MC, 100%), 172 (90), 158 (10). The second products
4.3. Intermolecular radical reactions
4.3.1. General procedure for reactions of the imidazol-5-
yl radical 2 with benzene and p-xylene; 5-phenyl-1,2-
dimethylimidazole 5 and 2-[1,6-trans-6-(1,2-dimethyli-
midazol-5-yl)-2,4-cyclohexadien-1-yl]-2-methylpropane-
nitrile 6. Bu3SnH (2.2 ml, 8 mmol) and AIBN (3.51 g,
21.4 mmol) in benzene (50 ml) was added over 18 h via a
syringe pump to 5-bromo-1,2-dimethyimidazole 1 (0.96 g,
5.3 mmol) and AIBN (0.88 g, 5.3 mmol) in benzene
(90 ml). The reaction was refluxed for a further 1 h, cooled
and evaporated to dryness. 2 M HCl (50 ml) added, and tin
residues were eliminated by repeated washing with hexane
(z20!50 ml). The acidic solution was neutralised with
solid Na2CO3 and the pH brought up to 14 by addition of
NaOH pellets. The solution was extracted with CH2Cl2 (2!
50 ml), dried (MgSO4) and evaporated to dryness to yield a
yellow residue, which was purified by column chromatog-
raphy on neutral alumina using mixtures of ethyl acetate and
hexane as eluent. The first product eluted was 5 (0.32 g,
35%) as white crystals, mp 71–75 8C (lit.27 74 8C). (Found
1
eluted were an inseparable 1:1 mixture (by H NMR) of 9
and 10 (0.50 g, 48%) as a yellow oil. (Found MC, 173.0952,
C10H11N3 requires MC 173.0953); 9, dH 2.47 (s, 3H, Im-2-
Me), 3.55 (s, 3H, N–Me), 7.02 (s, 1H, Im-4-H), 7.37 (dd, JZ
4.8, 8.2 Hz, 1H, Py-5-H), 7.68 (d, JZ8.2 Hz, 1H, Py-4-H),
8.59 (d, JZ4.8 Hz, 1H, Py-H-6), 8.64 (s, 1H, Py-2-H); 10,
dH 2.36 (s, 3H, Im-2-Me), 3.63 (s, 3H, N–Me), 7.14 (s, 1H,
Im-4-H), 7.29 (d, JZ6.0 Hz, 2H, Py-3,5-H), 8.63 (d, JZ
6.0 Hz, 2H, Py-2,6-H).
MC, 172.1003, C11H12N2 requires MC 172.1000), nmax
/
cmK1 3372, 1604, 1638, 1506, 1145; dH 2.45 (s, 3H, Im-2-
Me), 3.50 (s, 3H, N–Me), 6.95 (s, 1H, Im-4-H), 7.40 (m, 5H,
Ar-H); dC 13.6 (Me), 31.2 (N–Me), 125.8 (Im-4-CH), 127.5,
128.5, 128.6, 130.5, 133.4, 145.9 (Im-2-C); m/z 172 (MC,
100%), 130 (5), 118 (8). The second product eluted was 6
(0.32 g 25%) as white crystals; mp 105–106 8C. (Found:
MC, 241.1579. C15H18N3 requires M, 241.1573); nmax/cmK
1 2233 (CN), 1411, 1182; dH 1.32 (s, 3H, CMeCN), 1.36 (s,
3H, CMeCN), 2.31 (s, 3H, Im-2-Me), 2.49 (d, JZ5.6 Hz,
1H, diene-1-H), 3.53 (s, 3H, N–CH3), 3.69 (d, JZ5.6 Hz,
1H, diene-6-H), 5.47 (dd, JZ5.6, JZ9.6 Hz, 1H, diene-2-
H), 5.71 (dd, JZ5.6, 9.2 Hz, 1H, diene-5-H), 5.97 (dd, JZ
5.2, 9.2 Hz, 1H, diene-4-H), 6.17 (dd, JZ5.2, 9.6 Hz, 1H,
diene-3-H), 6.62 (s, 1H, Im-4-H); dC 13.5 (Im-2-Me), 21.6
(CMeCN), 24.3 (CMeCN), 29.0 (N–Me), 31.9 (CCN), 38.9
(diene-CH), 45.5 (diene-CH), 120.27 (CH), 123.1 (CN),
125.3 (CH), 126.1 (Im-5-C), 126.5 (CH), 127.1 (CH), 128.5
(CH), 145.7 (Im-2-C); m/z 241 (MC, 100%), 226 (39), 173
(87), 147 (39), 132 (32), 117 (29), 91 (10).
The above procedure was repeated with 4-picoline replacing
pyridine. The first product eluted by column chromatog-
raphy was 2-(1,2-dimethylimidazol-5-yl)-4-methylpyridine
11 (0.22 g, 20%) as a yellow oil. (Found MC, 187.1108.
C11H13N3 requires MC 187.1109); nmax/cmK1 1659, 1604,
1507, 1436, 1401; dH 2.36 (s, 3H, Im-2-Me), 2.44 (s, 3H, Py-
Me), 3.88 (s, 3H, N–Me), 6.96 (d, JZ5.2 Hz, 1H, Py-5-H),
7.29 (s, 1H, Im-4-H), 7.34 (s,1H, Py-3-H), 8.44 (d, JZ
5.2 Hz, 1H, Py-6-H); dC 13.5 (Im-2-Me), 20.9 (Py-Me), 32.4
(N–Me), 113.4 (C), 122.2 (CH), 122.4 (CH), 128.0 (CH),
131.6 (C), 147.5 (C), 148.8 (Py-6-CH), 150.6 (C); m/z 187
(MC, 100%). The second product eluted was 3-(1,2-
dimethylimidazol-5-yl)-4-methylpyridine 12 (0.39 g, 36%)
as a yellow oil. (Found MC, 187.1110, C11H13N3 requires
MC 187.1109); nmax/cmK11659, 1604, 1507, 1436, 1401;
dH 2.24 (s, 3H, Im-2-Me), 2.47 (s, 3H, Py-Me), 3.34 (s, 3H,
N–Me), 6.90 (s, 1H, Im-4-H), 7.24 (d, JZ5.7 Hz, 1H, Py-5-
H), 8.41 (s, 1H, Py-2-H), 8.49 (d, JZ5.7 Hz, 1H, Py-6-H);
dC 13.4 (Im-2-Me), 19.3 (Py-Me), 30.5 (N–Me), 124.9 (CH),
126.4 (C), 127.1 (CH), 128.1 (C), 145.9 (C), 1473 (C), 149.4
(CH), 151.0 (CH); m/z 187 (MC, 100%).
The above procedure was repeated with p-xylene replacing
benzene. 5-(2,5-Dimethylphenyl)-1,2-dimethylimidazole 7
(0.16 g, 15%) was isolated as a yellow oil. (Found MC,
200.1311, C13H16N2 requires MC 200.1313), nmax/cmK1
2920, 1613, 1559, 1505, 1435, 1403; dH 2.13 (s, 3H, Me),
2.33 (s, 3H, Me), 2.43 (s, 3H, Me), 3.29 (s, 3H, N–Me), 6.81
(s, 1H, Im-4-H), 7.00 (s, 1H, Ar-H), 7.11 (d, JZ7.8 Hz, 1H,
Ar-H), 7.17 (d, JZ7.8 Hz, 1H, Ar-H); dC 13.3 (Im-Me),
19.3 (Me), 20.6 (Me), 30.6 (N–Me), 125.3, 127.5, 128.5,
128.6, 130.5 133.4, 145.9 (Im-2-C); m/z 200 (MC, 100%),
158 (33).
The above procedure was repeated with bromobenzene
replacing 1. The first product eluted by column chromatog-
raphy was 4-methyl-2-phenylpyridine 1328 (0.21 g, 20%) as
a yellow oil. (Found MC 169.0895, C12H11N requires
169.0891), nmax/cmK1 3026, 1590, 1556, 1478, 1444, 1401;
dH 2.38 (s, 3H, Me), 7.03, (d, JZ4.8 Hz, 1H, Py-5-H), 7.43
(m, 3H, Ph-H), 7.53, (s, 1H, Py-3-H), 7.96 (m, 2H, Ph-H),
8.53 (d, JZ4.8 Hz, 1H, Py-6-H); dC 21.1 (Me), 121.4 (CH),
123.0 (CH), 126.9 (CH), 128.7 (CH), 139.5 (C), 147.6 (C),
149.3 (Py-6-CH), 157.3 (Py-2-C); m/z 170 (MHC, 2%), 169
(81), 168 (100), 167 (19), 154 (3). The second product
eluted was 4-methyl-3-phenylpyridine 14 (0.35 g, 36%) as a
yellow oil. (Found MC 169.0889, C12H11N requires
169.0891), nmax/cmK1 3026, 1590, 1556, 1478, 1444,
1401; dH 2.28 (s, 3H, Me), 7.18 (d, JZ4.9 Hz, 1H, Py-5-
H), 7.31–7.46 (m, 5H, Ph-H), 8.44 (bs, 2H, Py-2 and 6-H);
4.3.2. General procedure for reactions of the imidazol-5-
yl 2, imidazol-2-yl 19 and phenyl radicals with pyridines;
2-(1,2-dimethylimidazol-5-yl)-pyridine 8, 3-(1,2-
dimethylimidazol-5-yl)pyridine 9 and 4-(1,2-dimethyli-
midazol-5-yl)pyridine 10. Bu3SnH (2.5 ml, 9 mmol) and
AIBN (2.46 g, 15 mmol) in pyridine (50 ml) was added over